INS and diabetes mellitus: It accounts for approximately 96% of all diabetes cases and is characterized by (a) non-autoimmune, progressive loss of adequate insulin secretion by pancreatic β-cells within the islets of Langerhans, (b) IR, and (c) MetS [7,8].